[2型糖尿病降糖治疗指南（2023年更新版）]
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].
作者信息
Clodi Martin, Abrahamian Heidemarie, Brath Helmut, Schernthaner Guntram, Brix Johann, Ludvik Bernhard, Drexel Heinz, Saely Christoph H, Fasching Peter, Rega-Kaun Gersina, Föger Bernhard, Francesconi Claudia, Fröhlich-Reiterer Elke, Kautzky-Willer Alexandra, Harreiter Jürgen, Luger Anton, Resl Michael, Riedl Michaela, Winhofer Yvonne, Hofer Sabine E, Hoppichler Friedrich, Huber Joakim, Kaser Susanne, Ress Claudia, Lechleitner Monika, Aberer Felix, Mader Julia K, Sourij Harald, Toplak Hermann, Paulweber Bernhard, Stechemesser Lars, Pieber Thomas, Prager Rudolf, Stingl Harald, Stulnig Thomas, Rami-Merhar Birgit, Drexel Heinz, Roden Michael, Schelkshorn Christian, Wascher Thomas C, Weitgasser Raimund, Zlamal-Fortunat Sandra
机构信息
ICMR - Institute for Cardiovascular and Metabolic Research, Johannes Kepler Universität Linz JKU Linz, Altenberger Straße 69, 4040, Linz, Österreich.
Abteilung für Innere Medizin mit Diabetologie, Gastroenterologie und Hepatologie, Rheumatologie und Intensivmedizin, , Konventhospital der Barmherzigen Brüder Linz, Linz, Österreich.
出版信息
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):32-44. doi: 10.1007/s00508-023-02186-4. Epub 2023 Apr 20.
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
高血糖显著导致糖尿病患者出现并发症。虽然生活方式干预仍然是疾病预防和治疗的基石，但大多数2型糖尿病患者最终仍需要药物治疗来控制血糖。确定关于最佳治疗效果、安全性以及心血管效应的个体目标至关重要。在本指南中，我们为医疗保健专业人员提供了最新的循证最佳临床实践数据。
Zotero 插件